Pulmonary Kaposi's sarcoma after heart transplantation: a case report
© Fritzsche et al; licensee BioMed Central Ltd. 2010
Received: 18 September 2009
Accepted: 5 July 2010
Published: 5 July 2010
Kaposi's sarcomas have been associated with different conditions of immunosuppression and are also known to be a typical complication of solid organ transplantations.
We report the case of a 65-year-old Turkish man with a history of heart transplantation 10 months ago who presented for clarification of his dyspnea. The patient had a known history of chronic obstructive pulmonary disease and a smoking history of 40 pack years. Radiologically, three progressively growing intra-pulmonary nodules were detected. The histology was diagnostic for a Kaposi's sarcoma. Visceral and especially primary intra-pulmonary Kaposi's sarcomas are very rare and have been described to have a rather unfavorable prognosis.
Even with a history suggestive for conventional lung cancer, Kaposi's sarcomas should be considered in patients after transplantation of solid organs. It should be noted that in a minority of cases this tumor exists in the absence of the typical cutaneous lesions.
Kaposi's sarcomas are infrequent malignant tumors in the USA derived from vasoformative mesenchyme with a higher regional prevalence (endemic form) in the Mediterranean basin, the Middle East and Eastern Europe and in immunocompromised patients . The latter encompasses mainly patients with acquired immunodeficiency syndrome (AIDS) and to a lesser extent individuals with other causes of compromised immunity, for example after solid organ transplantation (so called iatrogenic forms). It was estimated that the frequency of Kaposi's sarcoma in AIDS patients is still several hundred times higher than that in immunocompromised patients of other causes . Classic (cutaneous) Kaposi's sarcoma typically manifests as bluish-red, well demarcated, painless dermal maculae, plaques or nodules in the distal lower extremities, which can become pedunculated and may ulcerate. Advanced lesions might display a brown color and hyper-keratotic surfaces. In addition to mucosal involvements visceral tumors (lymph nodes, gastrointestinal tract, lung, spleen) have been described for advanced cases and rarely as primary manifestations . Most Kaposi's sarcomas were found in individuals older than 50 years with a clear male predominance. The course of these tumors is generally prolonged, although short courses have been described .
In the 1990 s the connection between the human herpes virus 8 (HHV8) and Kaposi's sarcomas was established. Virtually all Kaposi's sarcomas are thought to harbor this virus which can be detected by immunohistochemical and molecular-pathological techniques .
In this case report we describe the rare case of a primary intra-pulmonary Kaposi's sarcoma in a human immunodeficiency virus (HIV)-negative 65-year-old man with a history of heart transplantation 10 months previously.
A 65-year-old Turkish man presented to the hospital for clarification of dyspnea. Computed tomography (CT) showed a small tumor in the lower lobe of the left lung. Subsequent bronchial lavage was non-contributive concerning possible viral, bacterial (including mycobacteria) and fungal causes or malignancy. It was decided to perform a follow-up CT in three months.
In the post-operative course our patient was transferred to the intensive care unit for two days for short-term intubation owing to pulmonary edema and reduced diuresis. He recovered well and was transferred back to the normal ward. Heart and lung function were normal. Our patient was able to leave hospital on the tenth post-operative day. Immunosuppressive therapy was changed from cyclosporine to everolimus and a follow-up CT in three months was arranged. In the meantime the immunosuppressive therapy might be further adapted to a possible chemotherapy.
Iatrogenic (post-transplantation) Kaposi's sarcomas are most often detected in patients with a previous history of kidney transplantation, which reflects the higher frequency of these transplantations. The rate of post-transplantation Kaposi's sarcoma was estimated at about 0.5% (range 0.06% to 4.1%). The majority of cases, including the one described, have been of patients originating from the Mediterranean, the Middle East area or African regions, known for the endemic form of this tumor entity. For some of the patients with iatrogenic Kaposi's sarcoma the hypothesis is that the tumor cells originated from infected progenitor cells received from the donated organ.
Purely visceral Kaposi's sarcomas after heart transplantation
Author; year of publication
No. of patients
Bhoopchand A; 1986 
Lopez-Rubio F; 1994 
bone, lungs, gastrointestinal, lymph nodes and liver
Fonesca R; 1998 
gastrointestinal and lung
Jones D; 1998 
Collart F; 2004 
gums, tonsils, lymph nodes
Wasywich CA; 2006 
Wasywich et al. reported the case of a 42-year-old man who had developed multiple intra-pulmonary Kaposi's sarcomas 28 days after heart transplantation . As in our case no other tumor nodules were detected. For the patient in Wasywich's case a remission for about two years was achieved by switching from cyclosporine and azathioprine to sirolimus. However, eventually lymph node metastasis occurred .
Cases of primary pulmonary Kaposi's sarcoma were mostly associated with AIDS, but have also been described as rare complications of other solid organ transplantations . Like involvement of other visceral organs, most cases represent primary cutaneous Kaposi's sarcomas with additional visceral components [2, 4]. Only one case of an immunocompetent young man with pulmonary Kaposi's sarcoma has been described so far .
Typical but unspecific radiological features of Kaposi's sarcoma in such patients were nodular or reticular opacities, pleural effusions and hilar/mediastinal lymphadenopathy.
Interestingly, in contrast to our case, most reports in the literature describe primary and secondary pulmonary Kaposi's sarcoma with multiple nodular manifestations. Although this case underlines that, even in the absence of skin manifestations, one should consider Kaposi's sarcoma as a possible cause of an intra-pulmonary tumor, common lung cancers (especially adenocarcinomas) are also important and frequent differential diagnoses in heart transplant patients.
For post-transplantation patients with Kaposi's sarcoma the five-year survival rate was observed at about 68% and these patients had a rather high rate of visceral involvement (47%) . Since many patients - including our own - received cyclosporine, it is thought that there might be causative connection. Several studies suggest that the omission of cyclosporine might lead to tumor remission . Complete remission of Kaposi's sarcomas was described using a combination of immunomodulation (reduced/changed immunosuppression), irradiation and surgery . However, for patients with visceral involvement, as well as for those with previous heart transplantation, the prognosis was worse than for other post-transplantation Kaposi's sarcoma cases . Woodle et al. therefore recommended a more aggressive combination therapy in such cases .
In conclusion we report a rare case of Kaposi's sarcoma following heart transplantation with primary intra-pulmonary manifestation without skin lesions. Even with a history suggestive for lung cancer, Kaposi's sarcoma should be considered as a differential diagnosis in patients after transplantation of solid organs. The prognosis of patients with visceral Kaposi's sarcoma seems to be rather serious and requires intensive follow-up and consideration of different therapeutic measurements.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R: Classic kaposi sarcoma: epidemiology and risk factors. Cancer. 2000, 88 (3): 500-517. 10.1002/(SICI)1097-0142(20000201)88:3<500::AID-CNCR3>3.0.CO;2-9.View ArticlePubMedGoogle Scholar
- Euvrard S, Kanitakis J, Claudy A: Skin cancers after organ transplantation. N Engl J Med. 2003, 348 (17): 1681-1691. 10.1056/NEJMra022137.View ArticlePubMedGoogle Scholar
- Piselli P, Busnach G, Citterio F, Frigerio M, Arbustini E, Burra P, Pinna AD, Bresadola V, Ettorre GM, Baccarani U: Risk of Kaposi sarcoma after solid-organ transplantation: multicenter study in 4,767 recipients in Italy, 1970-2006. Transplant Proc. 2009, 41 (4): 1227-1230. 10.1016/j.transproceed.2009.03.009.View ArticlePubMedGoogle Scholar
- Sharif-Kashani B, Ahmadi ZH, Bikdeli B, Tabarsi P, Dorudinia A, Shahabi P, Raeissi S, Shadafza B, Estahbanati G, Naji A: Bilateral diffuse pulmonary infiltration in a heart transplant recipient. Transpl Infect Dis. 2009,Google Scholar
- Wasywich CA, Croxson MC, van Doornum GJ, Coverdale HA, Ruygrok PN: Sirolimus for Kaposi's sarcoma. J Heart Lung Transplant. 2006, 25 (6): 726-729. 10.1016/j.healun.2006.01.010.View ArticlePubMedGoogle Scholar
- Ghorbani A, Mozafari A, Karimi S, Ehsanpour A, Aref A: Isolated primary pulmonary Kaposi's sarcoma in a renal transplant recipient: a case report. Transplant Proc. 2007, 39 (10): 3471-3473. 10.1016/j.transproceed.2007.03.113.View ArticlePubMedGoogle Scholar
- Antman KH, Nadler L, Mark EJ, Montella DL, Kirkpatrick P, Halpern J: Primary Kaposi's sarcoma of the lung in an immunocompetent 32-year-old heterosexual white man. Cancer. 1984, 54 (8): 1696-1698. 10.1002/1097-0142(19841015)54:8<1696::AID-CNCR2820540835>3.0.CO;2-Q.View ArticlePubMedGoogle Scholar
- Woodle ES, Hanaway M, Buell J, Gross T, First MR, Trofe J, Beebe T: Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry. Transplant Proc. 2001, 33 (7-8): 3660-3661. 10.1016/S0041-1345(01)02577-5.View ArticlePubMedGoogle Scholar
- Bhoopchand A, Cooper DK, Novitzky D, Rose AG, Reichart B: Regression of Kaposi's sarcoma after reduction of immunosuppressive therapy in a heart transplant patient. J Heart Transplant. 1986, 5 (6): 461-464.PubMedGoogle Scholar
- Lopez-Rubio F, Anguita M, Arizon JM, Lopez-Beltran A, Mesa D, Lopez-Granados A, Valles F, Concha M: Visceral Kaposi's sarcoma without mucocutaneous involvement in a heart transplant recipient. J Heart Lung Transplant. 1994, 13 (5): 913-915.PubMedGoogle Scholar
- Fonseca R, Witzig TE, Olson LJ, Edwards BS, Khoor A, Walker RC: Disseminated Kaposi's sarcoma after heart transplantation: association with Kaposi's sarcoma-associated herpesvirus. J Heart Lung Transplant. 1998, 17 (7): 732-736.PubMedGoogle Scholar
- Jones D, Ballestas ME, Kaye KM, Gulizia JM, Winters GL, Fletcher J, Scadden DT, Aster JC: Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. N Engl J Med. 1998, 339 (7): 444-449. 10.1056/NEJM199808133390705.View ArticlePubMedGoogle Scholar
- Collart F, Kerbaul F, Damaj G, Zandotti C, Vey N, Mesana T, Mouly-Bandini A: Visceral Kaposi's sarcoma associated with human herpesvirus 8 seroconversion in a heart transplant recipient. Transplant Proc. 2004, 36 (10): 3173-3174. 10.1016/j.transproceed.2004.10.058.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.